Single radiation treatment after lumpectomy for early breast cancer
Part of Cancer, Skin clinical trials.
This trial tests a single, targeted radiation treatment given during or after lumpectomy for early-stage breast cancer. It aims to make treatment more convenient while keeping the same safety and effectiveness as longer radiation courses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 40 to 85.
- You have been diagnosed with DCIS (non-invasive) or early invasive breast cancer that is 3 cm or smaller.
- You have had a lumpectomy and the edges of the removed tissue are free of cancer.
- If your cancer is HER2-positive, you are planning to get or have already received HER2-targeted therapy.
- For invasive cancer, lymph node testing (sentinel node biopsy or axillary dissection) shows no cancer spread, unless you are 70 or older with a low-risk tumor (ER+, grade 1-2, 2 cm or smaller).
- You can start brachytherapy (internal radiation) within 12 weeks after surgery or chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a very short, high-dose radiation treatment given directly to the breast after lumpectomy. It aims to make radiation more convenient by finishing in just a few days instead of weeks, possibly with fewer side effects.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial tests giving a single, very targeted dose of radiation right after surgery for early-stage breast cancer. It is for women age 40+ with small, low-risk tumors (Luminal A or B) that have been fully removed and have not spread to lymph nodes.
This trial tests a short, highly targeted radiation plan given in five sessions after lumpectomy for early-stage breast cancer. It may help treat the remaining breast area while aiming to limit exposure to healthy tissue.
This trial studies a type of radiation made with protons to treat only part of the breast after surgery (lumpectomy) for early-stage breast cancer. It may help control the cancer while aiming to reduce radiation to surrounding tissues.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.